bioRxivGeneticsPreprint
Targeted single-nucleus sequencing of 39,800 neurons reveals extensive low-frequency somatic variants
Vanshika BidhaniD, Sarah WynantsiD, Toon SwingsiD, Cristina T VicenteiD, Fahri KüçükaliiD, Marleen Van den BroeckiD, Jeroen van RooijiD, Merel O. MoliD, Laura Donker KaatiD, Safa Al-Sarraj, István BódiiD, Andrew KingiD, Claire TroakesiD, Christos ProukakisiD, Jolien M. SchaeverbekeiD, Dietmar Rudolf ThaliD, Rik R. VandenbergheiD, Mathieu VandenbulckeiD, Aivi T. NguyeniD, Robert Ross ReichardiD, Julia KofleriD, Oscar L. LópeziD, Charles L. WhiteiD, Bradley F. BoeveiD, Neill R. Graff‐RadfordiD, , Rosa RademakersiD
Abstract
Recent evidence implicates somatic mutations in disease-associated genes across multiple neurodegenerative disorders, including the identification of two somatic TARDBP variants as a putative cause of frontotemporal lobar degeneration with TDP-43 pathology type C (FTLD-TDP type C). However, these findings remain anecdotal. We performed single-nucleus amplicon sequencing of 39,800 neurons from the superior temporal gyrus of sporadic FTLD-TDP type C patients (34,738 neurons, 52 individuals) and non-demented controls (5,062 neurons, 26 individuals) using the Mission Bio Tapestri platform and investigated somatic variants in TARDBP and other FTLD-TDP-associated genes in a case-control setting. We uncovered an extensive landscape of ultra-low-frequency (<1%) somatic mutations across all analysed genes, including TARDBP. Rare somatic occurrences of known ALS/FTD-associated germline TARDBP variants, including p.N267S and p.M337V, were identified exclusively in patients. Among all targeted genes, TARDBP had the highest proportion of neurons harbouring a somatic variant, and this mutational burden was lower in individuals who died at an older age. Strikingly, the C-terminal domain of TDP-43, where most ALS/FTD germline pathogenic variants reside, exhibited a lower neuronal mutational burden than its other domains. This suggests that neurons harbouring damaging mutations may undergoprogressive loss prior to autopsy, leaving only rare survivors at frequencies too low to detect by bulk or small-scale single-cell approaches. Together, our findings provide an unprecedented resolution into the somatic mutational landscape of post-mitotic neurons in FTLD-TDP type C and reveal a gene-specific layer of neuronal mosaicism that current single-cell WGS studies fail to detect.
- organism: human
- assay: scRNA-seq
- research focus: differential expression
- research focus: variant calling
- research focus: gene regulatory network inference
- research focus: benchmarking
- approach: statistical model
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Somatic mosaicism in amyotrophic lateral sclerosis and frontotemporal dementia identifies focal mutations associated with widespread degeneration
Zinan Zhou, Junho Kim, … Christopher A. Walsh·bioRxiv·Nov 30, 2023
- Neurons accumulate disease-specific somatic genomic changes across taupathologic states in Alzheimer's disease
Bowen Jin, Katherine Sun-Mi Brown, … Michael B. Miller·bioRxiv·May 26, 2025
- Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders
Zinan Zhou, Lovelace J. Luquette, … Christopher A. Walsh·CellPeer-reviewed·Jul 1, 2026
- Concurrent tau pathologies in frontotemporal lobar degeneration with TDP-43 pathology
S. Koga, X. Zhou, … D. W. Dickson·Neuropathology and Applied NeurobiologyPeer-reviewed·Feb 1, 2022
- Rapid and automated quantification of TDP-43 and FUS mislocalisation for screening of frontotemporal dementia and amyotrophic lateral sclerosis gene variants
Lisa J. Oyston, Stephanie Ubiparipovic, … Carol Dobson‐Stone·Scientific ReportsPeer-reviewed·Jul 21, 2021
- The genetics of TDP43-Type-C neurodegeneration: a whole genome sequencing study
Malik M. Nassan, Iván Alejandro De León Ayala, … Matthew J. Huentelman·medRxiv·Jan 25, 2025